Accelerate diagnostics submits 510(k) application to fda for gram-negative menu expansion and breakpoint updates for the accelerate phenotest® bc kit

Tucson, ariz. , dec. 19, 2022 /prnewswire/ -- accelerate diagnostics, inc. (nasdaq: axdx) today announced that the company has submitted a 510(k) application to the fda for gram-negative menu expansion and breakpoint updates for the accelerate phenotest® bc kit.
AXDX Ratings Summary
AXDX Quant Ranking